ABCL vs OGN: stock comparison and AI forecast
Abcellera Biologics Inc. (ABCL) and Organon & Co. (OGN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ABCL Abcellera Biologics Inc.
- Price
- $11.88 +146.5% · 6M
- Market Cap
- $3.64B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
OGN Organon & Co.
- Market Cap
- $3.64B
- P/E Ratio
- 19.5x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ABCL and OGN have similar market capitalizations ($3.64B and $3.64B).
- OGN turns 3.5% of its revenue into net income, against -233.9% for ABCL.
- OGN carries 10.23 times debt per unit of equity, against 0.46 times for ABCL.
- OGN yields 4.50% in dividends; ABCL pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ABCL | OGN |
|---|---|---|
| Market Cap | $3.64B | $3.64B |
| P/E Ratio | – | 19.54x |
| P/B Ratio | 4.07x | 3.05x |
| Dividend Yield | – | 4.50% |
| EPS | $-0.55 | $0.71 |
| Book Value/Share | $2.92 | $4.54 |
| Revenue/Share | $0.23 | $23.22 |
| FCF/Share | $-0.39 | $2.57 |
Profitability & Margins
| Metric | ABCL | OGN |
|---|---|---|
| ROE | -18.4% | 17.9% |
| ROA | -12.6% | 1.6% |
| ROIC | -17.9% | – |
| Gross Margin | – | 53.1% |
| Operating Margin | -319.8% | – |
| Net Margin | -233.9% | 3.5% |
| EBT Margin | -279.5% | 8.2% |
| Tax Rate | 16.3% | 57.6% |
Financial Health
| Metric | ABCL | OGN |
|---|---|---|
| Current Ratio | 12.77x | 2.02x |
| Quick Ratio | 12.63x | 1.51x |
| D/E Ratio | 0.46x | 10.23x |
| Financial Leverage | 1.46x | 11.23x |
| Working Capital | $626M | $2.72B |
Cash Flow
| Metric | ABCL | OGN |
|---|---|---|
| Operating Cash Flow | -$95M | $843M |
| Free Cash Flow | -$120M | $675M |
| Capital Spending | -$25M | -$168M |
| OCF Growth YoY | – | -11.2% |
| FCF Growth YoY | – | -13.1% |
| FCF/Sales | -170.0% | 11.1% |
| CapEx/Sales | 35.1% | 2.8% |
Operational Efficiency
| Metric | ABCL | OGN |
|---|---|---|
| Asset Turnover | 0.05x | 0.46x |
| Receivables Turnover | 1.8x | 4.1x |
| Inventory Turnover | – | 2.1x |
| Fixed Assets Turnover | – | 4.7x |
| Days Sales Outstanding | 199 days | 89 days |
| Days Inventory | – | 173 days |
| Payables Period | – | 125 days |
| Cash Conversion Cycle | – | 136 days |
Income Statement
| Metric | ABCL | OGN |
|---|---|---|
| Total Revenue | $70M | $6.10B |
| Operating Income | -$225M | – |
| Net Income | -$165M | $213M |
| R&D Expense | $198M | $357M |
| SG&A Expense | $173M | $1.71B |
| Cost of Goods Sold | – | $2.86B |
Dividend & Shareholder Information
| Metric | ABCL | OGN |
|---|---|---|
| Dividends Per Share | – | $0.62 |
| Payout Ratio | – | 87.3% |
| Shares Outstanding | 307M | 263M |
| Net Income Growth | – | -57.5% |
| EPS Growth | – | -60.8% |
ABCL vs OGN: stock comparison and AI forecast
Which is bigger, ABCL or OGN?
ABCL and OGN have similar market capitalizations ($3.64B and $3.64B).
Which one does Intratio's AI model rank higher, ABCL or OGN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.